From: Rome consensus conference - statement; human papilloma virus diseases in males
Population type (n° males examined) | Country | Prevalence of positive HPV DNA (PCR test) | Prevalence of positive HPV DNA tests (high-risk genotypes) |
---|---|---|---|
Population (290) | USA | 30.0%; | 16.6%; |
Giuliano et al., 2007 [7] | |||
Military recruits (285) | Finland | 16.5%; | - - |
Hippelainen et al., 1993 [8] | |||
University students (317) | USA | 32.8%; | 14.5%; |
Weaver et al., 2004 [9] | |||
Students and industrial workers (114) | Mexico | 36.0%; | 16.7%; |
Lazcano-Ponce et al., 2001 [10] | |||
Military recruits (337) | Denmark | 33.8%; | - - |
Kjaier et al., 2005 [11] | |||
Military men (1030) | Mexico | 44.6%; | 34.8 |
Lajous et al., 2005 [12] | |||
University students (381) | South Korea | 8.7%; | 4.2%; |
Shin et al., 2004 [13] | |||
Subjects attending STD clinics (235) | Sweden | 13.2%; | 8.1%; |
Wikstrom et al., 2000 [14] | |||
Subjects attending STD clinics (198) | Denmark | 44.9%; | - - |
Svare et al., 2002 [15] | |||
Subjects attending STD clinics (393) | US | 28.2%; | 12.0%; |
Baldwin et al., 2003 [16] | |||
Subjects attending STD clinics (85) | Netherland | 28.2%; | - - |
Van Doornum et al., 1994 [17] | |||
Subjects attending STD clinics (204) | Japan | 5.9%; | 5.9%; |
Takahashi et al., 2005 [18] | |||
Males with female partner affected by CIN (119) | Netherland | 59.0%; | 55.4%; |
Bleeker et al., 2002 [19] | |||
Husbands of women recruited in case–control studies on carcinoma of the cervix (1143) | Thailand, Philippines, Brazil, Columbia, Spain | 16.0%; | - - |
Franceschi et al., 2002 [20] | |||
Males with female partner affected by CIN (181) | Netherland | 72.9%; | 58.6%; |
Bleeker et al., 2005 [21] | |||
Males with female partner affected by CIN (77) | Finland | 9.1%; | - - |
Hippelainen et al., 1994 [22] | |||
Males with female partner affected by HPV (50) | Brazil | 70.0%; | - - |
Nicolau et al., 2005 [23] | Â | ||
Males through 18–70 years from one of the three sampling sites (1,160) | Brazil | 65.2%; | 12.0%; oncogenic types only |
Giuliano et al., 2008 [6] | Mexico | ||
 | USA |  |  |